• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for brain

brain

OMRF receives $2.2 million to study brain cells

August 25, 2020

The National Institutes of Health has awarded OMRF scientist Tommy Lewis $2.2 million to study the inner workings of brain cells.

Filed Under: News Tagged With: aging, alzheimers, brain, cells, degeneration, dementia, disease, funding, grant, Holly, lab, Lewis, mira, mitochondiria, National Institutes of Health, neurodegeneration, news, newsok, NIH, OKC, Oklahoma, r35, research, science, scientist-news, Tommy, van remmen

An OMRF employee finds a new lease on life—at work

August 5, 2019

In MS, immune cells attack the protective covering of nerves in the brain, causing vision problems, tremors, paralysis, painful spasms, imbalance and cognitive changes.

Filed Under: News Tagged With: attack, autoimmune, brain, center, chrissy brady, clinic, cognitive, cure, disease, excellence, Gabriel, immunity, medication, MS, multiple sclerosis, newsok, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, outcomes, Pardo, scientist-news, treatment, trial

OMRF scientist receives Alzheimer’s grant

July 22, 2019

Alzheimer’s affects 5.8 million Americans, and one in three senior citizens dies with the disease or other forms of dementia.

Filed Under: News Tagged With: alzheimers, Beckstead, brain, dementia, depression, disease, dopamine, grant, Michael, national institute of aging, neurodegeneration, newsok, nia, NIH, OKC, Oklahoma Medical Research Foundation, OMRF, scientist-news, signs, symptoms

OMRF discovers compound that could fight deadly cancer

January 21, 2019

Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.

Filed Under: News Tagged With: biomedical, brain, brain cancer, cancer, compound, cure, developed, drug, eltd1, glioblastoma, john mccain, medicine, news, newsok, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, pharma, Rheal, rheal towner, scientist-news, ted kennedy, Towner, treat, treatment

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace